DÍAGEN Ai

Design | Innovate | Apply

Generative Ai for Protein Design

Integrating generative AI into protein and molecule design represents the key solutions to address global challenges across various industries, accelarating progress for a brighter future

Molecule Design Drug Discovery

Drug discovery and development is a long, costly, and high-risk process that takes over 10–15 years. We’re revolutionizing the industry by drastically shortening the process.

Beyond just another Generative AI play

New Era of Innovation for the Futur of Health

” Artificial Intelligence Revolutionizes Protein Design, Paving the Way for Unprecedented Medical Breakthroughs “

In a groundbreaking development, AI is being harnessed to engineer proteins that were previously beyond human conception. This remarkable innovation holds immense promise for unlocking novel solutions in the quest to combat diseases, offering the potential to expedite and economize the drug development process significantly.

Díagen platform, is revolutionizing innovation across various industries by addressing longstanding challenges. As a rising star in the field, Its AI platform has garnered endorsements from industry leaders. Its creators have subjected their publications to rigorous peer review, which has been featured in reputable journals and conferences. This cutting-edge AI platform for generative protein molecule design holds the potential to transform industries by accelerating advancements in areas ranging from drug discovery and healthcare to eco-friendly solutions, cosmetics, biosensors for detection, and stabilizing agents.

MORE SOLUTIONS

Real Life Application

Bind

MaximiseI binding function with a specific viral protein (e.g. COVID for detection)

Stabilize

Inside the gut (for ingestible devices)

Adhere

Formulate optimal adherence to chip surfaces (for biosensor production)

Stop

A cancer-causing protein (for therapeutics)

Generate

Predict and generate an immune response (for vaccine creation)

Degrade

Plastics (green solutions)

Protein & Molecule Design

Our Services

"DÍA" Engine

Use Día AI Engine to solve problem in your industry.

 

Outsource

Outsource our platform in your project or others projects.

 

Consultancy

We will guide and help through out the process  to solve problems using our Ai engine within your organisation.

Research

Partner with Diagen in synergetic project and research to accelerate advancement, innovation and mutual growth. 

Licensing

Licensing Díagen molecule for drug discovery and other industry novel molecule.

Select

Pipeline Partners

Why Choose us

Natural Videography & Photography

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris

  • High Quality
  • Best Photography
  • HD Resolution
  • High Quality
  • Best Photography
  • HD Resolution

Pricing Tables

Our Pricing Plan

Our Portfolio

Case Studies

Client Feedback

Testimonial

Richard Wagner

Customer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris

Joy Ander

Customer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris

Richard Wagner

Customer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris

Joy Ander

Customer

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Richard Wagner

Customer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris

Joy Ander

Customer

Recent Article

Latest News

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

DiaGen Ai Inc. Announces Partnership with Cambridge, UK Based The Vaccine Group LTD. to Co-Develop Novel Vaccines

DiaGen Ai Inc. is pleased to announce its partnership with The Vaccine Group LTD., based in Cambridge, UK, to develop novel vaccines for the veterinary market using DiaGen’s AI engine. This collaboration aims to optimize protein structures and advance TVG’s vaccine pipeline. TVG’s CEO, Jeremy Salt, highlighted the complementary AI approaches, while DiaGen’s President, Paolo Lobo, expressed excitement about entering the Veterinary sector.

read more
DiaGen Ai Inc., Announces Unit Financing and Appointment of Davidson & Company, LLP as Independent Auditor

DiaGen Ai Inc., Announces Unit Financing and Appointment of Davidson & Company, LLP as Independent Auditor

VANCOUVER, BC, CANADA, March 6, 2024 /EINPresswire.com/ — DiaGen AI Inc. announces a successful first closing of its non-brokered unit financing, raising $198,195. Each unit, priced at $0.135, includes one common share and one-half of a common share purchase warrant with an exercise price of $0.20. The financing aims to advance DiaGen’s proprietary AI engine, innovate peptides, and molecules, while scaling partnerships in health and wellness.

Highlights:

Successful First Tranche: Raised $198,195, issuing 1,468,116 common shares and 734,058 warrants.

Canaccord Genuity Corp. as finder.

read more
Proteic Biosciences Inc. Announces Name Change to DiaGen Ai Inc., the Appointment of a New CEO, New Website and Update

Proteic Biosciences Inc. Announces Name Change to DiaGen Ai Inc., the Appointment of a New CEO, New Website and Update

VANCOUVER, BC, CANADA, December 13, 2023 /EINPresswire.com/ — Proteic Biosciences Inc., now DiaGen AI Inc., pioneers in AI-driven protein design and drug discovery, reveals its corporate rebrand. Alongside, Brian D. Keane, former Proteic capital markets advisor, assumes the role of CEO and Chairman, bringing 30 years of legal and capital markets expertise.

Paolo Lobo, President of DiaGen AI, emphasizes, “Our rebrand showcases our focus as an AI company advancing healthcare through protein design and innovation.”

read more

Contact Us

Phone Number

Address

5919 Trussville Crossings Pkwy, Birmingham